Table 2.
Demographic and Clinical Characteristics at Enrollment
| Variable | Total (N = 31) N (%*) |
|---|---|
|
| |
| Age | |
| M (SD) | 58.9 (10.2) |
| Mdn (Range) | 58.0 (29–76) |
| Sex | |
| Female | 26 (83.9) |
| Male | 5 (16.1) |
| Race | |
| White | 21 (67.7) |
| Black | 1 (3.2) |
| Asian | 4 (12.9) |
| Middle Eastern | 1 (3.2) |
| Decline to answer | 4 (12.9) |
| Hispanic or Latino | |
| Yes | 7 (22.6) |
| No | 22 (71.0) |
| Decline to answer | 2 (6.5) |
| Education level | |
| Up to high school graduate or equivalency | 6 (19.4) |
| Some college, trade school, or vocational school | 11 (35.5) |
| Bachelor’s degree | 8 (25.8) |
| Graduate or professional degree | 6 (19.4) |
| Employment status | |
| Unemployed | 8 (25.8) |
| Retired | 13 (41.9) |
| Employed full time | 7 (22.6) |
| Employed part time | 1 (3.2) |
| Other job status | 2 (6.5) |
| Marital status | |
| Never married | 1 (3.2) |
| Married/domestic partnered | 21 (67.7) |
| Separated, devoiced, or widowed | 9 (29.0) |
| Annual income, $ | |
| <25,000 | 6 (19.4) |
| 25,000–50,000 | 2 (6.5) |
| 50,001–100,000 | 9 (29.0) |
| >100,000 | 8 (25.8) |
| Declined | 6 (19.4) |
| Cigarette smoking status | |
| Never | 19 (61.3) |
| Ever | 12 (38.7) |
| Pack years, M (SD) | 13.3 (14.0) |
| Primary care provider | |
| Yes | 24 (77.4) |
| No | 7 (22.6) |
| Diagnosis | |
| Ovarian cancer | 8 (25.8) |
| Uterine cancer | 8 (25.8) |
| Non-small-cell lung cancer | 15 (48.4) |
| Stage | |
| III | 14 (45.2) |
| IV | 17 (54.8) |
| Prior cancer recurrence | 20 (64.5) |
| No. of recurrence, M (SD) | 2.2 (1.1) |
| Recurrence during the study | 5 (16.1) |
| Local-regional recurrence | 2 |
| Distant metastasis recurrence | 1 |
| Unknown type | 2 |
| Cancer therapy | |
| Received prior to enrollment | |
| Chemotherapy | 27 (87.1) |
| Radiation therapy | 15 (48.4) |
| Surgery | 20 (64.5) |
| Immune therapy | 9 (29.0) |
| Target therapy | 14 (45.2) |
| Active treatment at enrollment | 21 (67.7) |
| Chemotherapy | 7 |
| Immunotherapy | 5 |
| Target therapy | 10 |
| Hormone therapy | 1 |
| Months from initial diagnosis to Session 1 | |
| M (SD) | 51.7 (35.2) |
| Mdn (range) | 44 (10–137) |
| Comorbidities | |
| M (SD) | 2.1 (1.8) |
| Mdn (range) | 2 (0–6) |
Abbreviations: M = Mean, Mdn = Median, SD = Standard Deviation.
*
Number in parenthesis is percentage, except where otherwise noted; percentages for each variable may not sum to 100% due to rounding.